Immunological deficiencies induced by some hydrazone derivatives of rifamycin SV.
D000818:Animals; D001666:Binding Sites, Antibody; D004305:Dose-Response Relationship, Drug; D006168:Guinea Pigs; D006801:Humans; D007109:Immunity / Q000187:drug effects; D007111:Immunity, Cellular / Q000187:drug effects; D007153:Immunologic Deficiency Syndromes / Q000139:chemically induced*; D007166:Immunosuppressive Agents / Q000009:adverse effects* / Q000494:pharmacology; D008214:Lymphocytes; D008264:Macrophages / Q000187:drug effects; D011817:Rabbits; D012293:Rifampin / Q000009:adverse effects / Q000494:pharmacology; D012294:Rifamycins / Q000009:adverse effects* / Q000494:pharmacology; D016038:Skin Transplantation; D013997:Time Factors; D014184:Transplantation, Homologous
D007166:Immunosuppressive Agents; D012294:Rifamycins; D012293:Rifampin